Dicerna Pharmaceuticals Inc. (NASDAQ: DRNA) was up 28% to $7.23 on Thursday, and while it posted another loss it also announced a collaboration agreement with Boehringer Ingelheim to develop novel chronic liver disease treatments. The firm H.C. Wainwright reiterated its Buy rating and raised its target to $10 from $6 on November 3. Other price targets were raised as well: Leerink to $7 from $4 and Stifel to $10 from $9. Dicerna shares closed at $7.78 on Friday, after earlier in the day hitting a new 52-week high of $8.23. The market cap here is just $162 million.
Green Plains Inc. (NASDAQ: GPRE) may have fallen by 7.6% to $16.77 on Thursday after earnings, but Piper Jaffray decided that this was finally an entry point into the ethanol and related products player. The firm raised Green Plains to Overweight from Neutral with a $25 price target, and its shares closed down 1% at $16.60 on Friday, in a 52-week trading range of $16.25 to $29.85. This remains a speculative stock, with the company’s many efforts around energy and also food-related products, and its market cap was less than $690 million on last look.
Rhythm Pharmaceuticals Inc. (NASDAQ: RYTM) may be a recent IPO, but its post–quiet period coverage showed at least some very aggressive upside targets. Merrill Lynch started the stock with a Buy rating and a $30 price objective on November 30. It was also started with an Outperform rating and assigned a $40 price target at Cowen. This stock ended the week at $25.89, and note that Morgan Stanley was only willing to assign an Equal Weight rating with a $23 price target. Rhythm Pharma shares have a post-IPO range of $21.38 to $33.81.
SunPower Corp. (NASDAQ: SPWR) saw its shares pop big after earnings, and Oppenheimer slashed its loss expectations in half for this year while maintaining earnings expectations for $0.15 per share next year. The company has an Outperform rating and maintained its $13 price target. SunPower shares were just above $7.00 ahead of earnings, but they closed $8.64 apiece on Friday. The 52-week range is $5.84 to $11.70, and the consensus target price was $9.08 on last look.
Turtle Beach Corp. (NASDAQ: HEAR) had a poor reception after earnings, with its shares down 13% at $0.63, and with a micro-cap of $33 million on Friday. The analyst reports seen were in contrast to that reaction, but investors need to understand that this is a highly speculative headset company.
Oppenheimer maintained its Outperform rating and $2.25 target price on November 3, noting that the company is on track to close out a turnaround year after a weaker-than-expected start to October and a shift in retailer inventory management. Wedbush maintained its Outperform rating and $1.50 target price after earnings, noting that revenue was light but that profitability is now in view.
YogaWorks Inc. (NASDAQ: YOGA) was started with an Outperform rating and assigned a $5 price target at Imperial Capital on October 3. The prior closing price was $2.77, but the shares closed up 2.9% ($0.08) at $2.89 Friday. Its post-IPO range is $2.41 to $5.85. YogaWorks just recently expanded by acquiring YogaOne’s seven locations in Houston, and the company has 62 studios in eight major U.S. markets. The company’s market cap is a mere $47 million.